Current Research Studies

Cancer – ANBL00B1: Neuroblastoma Biology Studies

Condition or Therapy:

Ganglioneuroblastoma, localized neuroblastoma


Cancer and Blood Disorders
Study Number: ANBL00B1

What is the goal of this study?

This study looks at biomarkers in patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Who can join the study?

This study may be a good fit for children and young adults who:

  • are up to 30 years old,
  • have been newly diagnosed with neuroblastoma or ganglioneuroblastoma, and
  • have not received chemotherapy yet.

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Julie Park